BNP Paribas Exane analyst Peter Verdult initiates coverage on Novartis (NOVN:SW) (NYSE: NVS) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE